Hyperthermic Yoga for Depressive Symptoms
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02607514 |
Recruitment Status :
Completed
First Posted : November 18, 2015
Last Update Posted : April 24, 2020
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Depression Major Depressive Disorder | Behavioral: hyperthermic yoga | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 80 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Mechanisms of Hyperthermic Yoga for the Treatment of Depression |
Actual Study Start Date : | February 20, 2017 |
Actual Primary Completion Date : | December 19, 2019 |
Actual Study Completion Date : | December 19, 2019 |
Arm | Intervention/treatment |
---|---|
Experimental: immediate yoga arm
participants will immediately start the 8-week hyperthermic yoga intervention
|
Behavioral: hyperthermic yoga
heated yoga, 90-minutes
Other Name: Bikram Yoga |
delayed yoga arm
participants will wait 8-weeks to start the 8-week hyperthermic yoga intervention
|
Behavioral: hyperthermic yoga
heated yoga, 90-minutes
Other Name: Bikram Yoga |
- Depressive symptoms as measured by the Inventory of Depressive Symptomatology - Clinician Rated (IDS-CR) [ Time Frame: 8-week primary endpoint ]
- Feasibility and tolerability measured by percent of the yoga group who complete a week 8 assessment [ Time Frame: 8-week primary end point ]measured by percent of the yoga group who complete a week 8 assessment
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
- Adults ages 18-60
- English language proficiency
- Ability to provide informed consent
- Score of >23 on the Inventory of Depressive Symptomatology - Clinician Rated (IDS-CR)
- Able and willing to attend two 90-minute hyperthermic yoga sessions per week
- Willingness to keep existing exercise regimen (even if that is sedentary) stable over study course
- Women of childbearing potential must use an acceptable form of birth control
- Membership to the Bikram Yoga Boston and Bikram Yoga Cambridge studios via studio website "Interested in research" option through a centralized portal (this will remain central until January 1, 2017)
- Willingness to adhere to hydration requirements (i.e., an additional four 8 oz servings of water pre- and post-yoga classes)
Exclusion Criteria
- Pregnancy or planned pregnancy during study
- History of psychiatric hospitalization within the past year
- Active suicidal intent within the past year ("yes" on item 4 or 5 on the Columbia-Suicide Severity Rating Scale)
- History of neurologic disorders that could interfere in study participation
- History of bipolar disorder, psychotic disorders, eating disorders, and/or substance abuse or dependence (within the last year), as per the Mini-International Neuropsychiatric Interview (MINI)
- Psychotropic medication use that has been stable for <3 months
- Use of stimulant medications or diet pills during the study, or any pre-workout powders or liquids designed to provide excessive energy
- Positive urine toxicology screen due to illicit drug use or other exclusionary medications. (Potential false positives will be addressed on a case-by-case basis at the discretion of the investigator)
- Active conditions which may also cause depressive symptoms (e.g. epilepsy, hypothyroidism)
- Medical conditions that may make participation unsafe (e.g., diabetes [I & II], cardiovascular disease, hypertension [>140 systolic and/or >90 diastolic], hypotension [<90 systolic and/or <60 diastolic, during screening], orthostatic hypotension [systolic drop of 20 points or 10 point diastolic or heart rate increase by 10], autoimmune disorders, malignancy, or autonomic dysfunction)
- > 6 one hour classes of meditation or other mind-body disciplines (e.g., Tai chi or yoga) within the last 6 months
- Current individual or group psychotherapy established for <3 months
- A subject who in the opinion of the Principal Investigator would not be able to safely complete the study or would jeopardize study integrity
- History of heat intolerance or heat stroke
- Unsafe cardiac status as defined by abnormal ECG reading at screening visit as determined by medical monitor, study doctor, or subject's PCP or cardiologist
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02607514
United States, Massachusetts | |
Depression Clinical and Research Program | |
Boston, Massachusetts, United States, 02114 |
Responsible Party: | Maren Nyer, Maren Nyer, PhD, Massachusetts General Hospital |
ClinicalTrials.gov Identifier: | NCT02607514 |
Other Study ID Numbers: |
2016P000704 |
First Posted: | November 18, 2015 Key Record Dates |
Last Update Posted: | April 24, 2020 |
Last Verified: | April 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Depression Depressive Disorder Depressive Disorder, Major |
Behavioral Symptoms Mood Disorders Mental Disorders |